References
- Means RT. Jr Pure red cell aplasia. Blood 2016;128:2504–2509.
- Korde N, Zhang Y, Loeliger K, et al. Monoclonal gammopathy-associated pure red cell aplasia. Br J Haemotol. 2017;173(6):876–883.
- Cerda S, Ballina B, Robles VM, et al. Multiple myeloma (mm) and pure red cell aplasia (prca): interesting diagnostic and therapeutic challenge. Clin Lymphoma Myeloma Leuk. 2017;17:e152.
- So CC, Choi WWL, Kwong YL. Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab. Ann Hematol. 2013;92:1425–1426.
- Lv Y, Qian W. Treatment of pure red cell aplasia associated with multiple myeloma with biclonal gammopathy using cyclosporine A: a case report. Int J Clin Exp Med 2015;8:1498–1500.
- Sarathy KS, Ramakrishna R, Baig WW, et al. Acquired pure red cell aplasia in patients with plasma cell neoplasm and long term remission with bortezomib therapy. J Hematol Malig 2014;3:37–44.
- Ladha A, Fudym Y, Gentile TC. Clinical resolution of red cell aplasia associated del 17p multiple myeloma, when treated with bortezomib and dexamethasone. J Hematol. 2018;7:29–31.
- Lang AS, Burkeholder SB, Park MH, et al. Red cell aplasia and monoclonal gammopathy: inhibition of erythroid progenitors by patient IgG. Baylor Univ Med Cent Proc. 1998;11:77–79.
- Gu H, Lee W-I, Jeon Y, et al. Pure red cell aplasia associated with monoclonal gammopathy of undetermined significance and literature review. Clin Lab 2017;63:1–2.
- Kyle RA, Therneau TM, Rajkumar SV, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362–1369.